CCM
DXCM icon

Chilton Capital Management’s DexCom DXCM Stock Holding History

Chilton Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-80
Closed -$5.02K – 620
2026
Q1 		$5.02K Buy
+80
New +$5.57K ﹤0.01% 540
2024
Q4 		– Sell
-39
Closed -$2.62K – 590
2024
Q3 		$2.62K Buy
39
+17
+77% +$1.4K ﹤0.01% 591
2024
Q2 		$2.5K Buy
+22
New +$2.78K ﹤0.01% 555
2023
Q2 		– Sell
-1,508
Closed -$175K – 554
2023
Q1 		$175K Buy
+1,508
New +$169K 0.01% 231
2022
Q3 		– Sell
-132
Closed -$10K – 323
2022
Q2 		$10K Buy
+132
New +$12K ﹤0.01% 466
2022
Q1 		– Sell
-84
Closed -$11K – 326
2021
Q4 		$11K Buy
+84
New +$12.1K ﹤0.01% 482

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Chilton Capital Management's DXCM Position: Q2 2026 in Review

Chilton Capital Management sold out of DexCom (DXCM) in Q2 2026, closing a stake of 80 shares — an estimated $5.02K sold.

Chilton Capital Management first reported a position in DXCM in Q4 2021 and held it in 6 quarters. The position peaked at $175K in Q1 2023. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Chilton Capital Management reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Chilton Capital Management sold 80 DexCom shares in Q2 2026, an estimated $5.02K.
  • Chilton Capital Management first reported a position in DexCom in Q4 2021 and held it in 6 quarters.
  • Chilton Capital Management's DexCom position peaked at $175K in Q1 2023.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.